Peter B. Corr
Imvax Co-Founder & Chairman of the Board at Imvax
Dr. Peter B. Corr is Co-Founder and Managing General Partner of Auven Therapeutics Management LLLP. Dr. Corr retired from Pfizer Inc in December 2006 where he was Senior Vice President for Science and Technology. He also headed worldwide pharmaceutical research and development for Pfizer. Previously, Dr. Corr served as Executive Vice President, Pfizer Global Research & Development, and President, Worldwide Development. He also served as Senior Vice President, Discovery Research, at Monsanto/Searle and then, President of Pharmaceutical Research and Development at Warner Lambert/Parke Davis. Dr. Corr, who received his doctorate from Georgetown University School of Medicine, spent 18 years as a researcher in molecular biology and pharmacology at Washington University in St. Louis. When he left Washington University, Dr. Corr was Professor, Department of Medicine (Cardiology) and Professor, Department of Pharmacology and Molecular Biology. His research has been published in more than 160 scientific manuscripts. Dr. Corr is the recipient of numerous awards, including membership in the Alpha Omega Alpha National Medical Honorary Society, an Established Investigator Award from the American Heart Association, and a Research Career Development Award from the National Institutes of Health. He received the Washington University Distinguished Faculty Award, as well as multiple Teacher of the Year awards. He is a past Governor of the New York Academy of Sciences (and past Chairman of the Board of Governors) and past member of the Board of Regents of Georgetown University. Additionally, he is Immediate Past Chair of the Board of the International Partnership for Microbicides, Chairman of the Board of Directors for the Critical Path Institute (retired in June, 2016 after 10 years), and Chairman of the Board of Directors for ADC Therapeutics, S.A. through the completion of its IPO in May, 2020. He served as a founding Board member on the Board of Directors of Furiex Pharmaceuticals, Inc. until the sale of the company in July, 2014. He is Chairman Emeritus of the Board of Patient Assist VI from its founding which provides medicines to indigent patients in the US Virgin Islands. He is a member of the National Council for Washington University School of Medicine and the Barnes Hospital Medical Center.
Imvax Co-Founder & Chairman of the Board